Mechanistically, downregulation of CRISPLD1 resulted in decreased intracellular calcium levels in GC cells, inhibited the activation of the PI3K-AKT signaling pathway, and suppressed GC tumor progression. The gene discussed is AKT1; the disease is gastric cancer.